This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Murthy, R. V. Articles by Sun, X.-F. Search for Related Content PubMed PubMed Citation Articles by Murthy, R. V. Articles by Sun, X.-F.

Legumain Expression in Relation to Clinicopathologic and Biological Variables in Colorectal Cancer

¹ Department of Oncology, Institute of Biomedicine and Surgery, University of Linköping, Linköping, Sweden; ² Department of Surgery, Vrinnevi Hospital, Norrköping, Sweden; and ³ Division of Hematology/Oncology, University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania

Requests for reprints: Xiao-Feng Sun, Department of Oncology, Institute of Biomedicine and Surgery, University of Linköping, S-581 85 Linköping, Sweden. Phone: 46-13-222066; Fax: 46-13-222846; E-mail: xiasu{at}ibk.liu.se.

Purpose: Legumain, a novel asparaginyl endopeptidase, has been observed to be highly expressed in several types of tumors including colorectal cancer. However, there is no study examining the relationship of legumain expression to clinocopathologic and biological variables in colorectal cancers.

Experimental Design: We investigated legumain expression in 164 primary colorectal cancers, 34 corresponding distant normal mucosa samples, 89 adjacent normal mucosa samples, and 33 lymph node metastases using immunohistochemistry. We also did Western blotting analysis on three additional colorectal cancers and three colonic cell lines.

Results: Legumain expression was increased in primary tumors compared with distant or adjacent normal mucosa (P < 0.05), but there was no significant change between primary tumors and metastases (P > 0.05). Legumain expression was positively related to poorer differentiation/mucinous carcinoma (P = 0.04), higher degree of necrosis (P = 0.03) and apoptosis (P < 0.0001), positive proliferating cell nuclear antigen (P < 0.0001) and p53 expression (P = 0.049), and had a positive tendency towards stromelysin 3 (P = 0.058) and PINCH positivity (P = 0.05). The patients with tumors that showed both weak and lower percentage of the legumain expression, either in tumor (P = 0.01) or in stroma (P = 0.04), had a better prognosis.

Conclusions: The legumain expression may be involved in colorectal cancer development and have a prognostic value in the patients.

Key Words: Legumain • prognosis • colorectal cancer • immunohistochemistry • Western blotting

This article has been cited by other articles:

				J. C. Strefford, F. W. van Delft, H. M. Robinson, H. Worley, O. Yiannikouris, R. Selzer, T. Richmond, I. Hann, T. Bellotti, M. Raghavan, et al. Complex genomic alterations and gene expression in acute lymphoblastic leukemia with intrachromosomal amplification of chromosome 21 PNAS, May 23, 2006; 103(21): 8167 - 8172. [Abstract] [Full Text] [PDF]